Free vaccination programme for shingles and pneumonia
aged 60 and over, as well as for risk groups
Applies only to existing patients.
From November 2025, we should be provided with vaccines against shingles (herpes zoster) and pneumonia (pneumococcus) as part of the free vaccination programme.
In order to cope with the large number of necessary vaccinations, we have decided on the following procedure:
- We will begin with vaccinations against pneumonia (pneumococcus) as part of our flu and COVID vaccination days starting on 4 November (subject to timely delivery of the vaccine).
- Due to the complex handling of the shingles vaccine, we will only begin with this after the seasonal vaccinations (flu/COVID) have been completed.
You can therefore also get vaccinated against pneumonia on 4 November 2025 and 18 November 2025 from 2 to 4 p.m. without an appointment.
The first opportunity to get vaccinated against shingles is on Thursday, 4 December 2025, from 2:00 p.m. to 4:00 p.m.
On 4 December 2025, vaccinations against pneumonia will also be available, and if there are any remaining stocks, vaccinations against influenza and COVID will also be available.
Risk groups according to the vaccination program
Pneumonia
- Secondary immunosuppression, such as HIV infection or drug-induced immunosuppression
- Before starting and during immunosuppressive therapy (especially therapy with biologics)
- Oncological diseases (especially lung cancer) and haematological oncological diseases
- The following chronic diseases that require treatment with prescription medication and regular medical check-ups, such as:
- Cardiovascular diseases (hypertension and atherosclerosis)
- Respiratory diseases (asthma, emphysema, COPD, chronic bronchitis)
- Diabetes mellitus or other metabolic diseases
- Cirrhosis of the liver
- Chronic renal failure
- Nephrotic syndrome
- Coeliac disease
- Smokers and chronic alcohol abusers over the age of 50
- People who are exposed to metal fumes at work (welding, metal cutting)
- Cochlear implants or cerebrospinal fluid fistula
- Functional or anatomical asplenia (sickle cell anaemia, other severe haemoglobinopathies, congenital or acquired asplenia)
- Immune deficiencies such as hypogammaglobulinaemia, complement and properdin/MBL deficiency
- Before and after organ transplants
- After stem cell transplantation (autologous and allogeneic) or CAR-T cell therapies
- Individuals after cerebrospinal fluid loss, e.g. due to trauma or skull surgery
Shingles (herpes zoster)
- Congenital or acquired immunodeficiency or suppression
- Stem cell transplantation, CAR T-cell therapies
- Haematological oncology patients and oncology patients
- HIV infection
- Systemic lupus erythematosus
- Rheumatoid arthritis (especially under JAK inhibitor therapy, anti-CD20, etc.)
- Individuals who require treatment with prescription medication and regular medical check-ups and suffer from the following conditions:
- Chronic obstructive pulmonary disease (COPD) and bronchial asthma
- Chronic inflammatory bowel disease
- Chronic kidney disease (insufficiency)
- Cardiovascular disease
- Diabetes mellitus